| 초록 |
Introduction and Aims: Glycated albumin (GA) is the major form of circulating Amadori-type glycated protein and
increased serum GA levels are associated with development of cardiovascular complications in diabetic patients. GA
production is also increased with aging, oxidative stress, coronary artery disease, obesity, and renal dysfunction. GA
exhibits potential atherogenic effects in endothelial cells as well as vascular smooth muscle cells and therefore cause
development of arterial stiffness. A cross-sectional study was carried out to further ascertain the association between
GA and arterial stiffness in nondiabetic chronic kidney disease (CKD) patients.
Methods: Arterial stiffness was measured by brachial-ankle pulse wave velocity (baPWV) using a volume plethysmographic
instrument(VP 1000, OMRON Healthcare, Japan) along with simultaneous measurements of GA in nondiabetic
CKD patients. Estimated glomerular filtration rate was calculated using serum creatinine (MDRD-GFR) and
cystatin C level (Cystatin C-GFR).
Results: A total of 134 non-diabetic CKD patients were enrolled. Serum glucose, GA, HOMA-β and HOMA-IR in
subjects were 96.2±12.4 mg/dL, 13.7±2.3 %, 109.7±101.2 and 2.4±4.0, respectively. Age-adjusted partial correlation
analysis showed that baPWV correlated significantly with GA (r=+0.198, p=0.024), pulse pressure (r=+0.331 p=0.000),
and mean blood pressure (r=+0.279 p=0.001). Cystatin C-GFR (r=-0.245, p=0.005), HDL-cholesterol level (r=-0.192,
p=0.028), and hemoglobin level (r=-0.172, p=0.049) showed significant negative correlation with baPWV. MDRDGFR,
serum glucose level, HOMA-β and HOMA-IR did not show the significant correlation with baPWV. Multiple
regression analysis revealed that pulse pressure, mean blood pressure, serum HDL-cholesterol, and GA level were the
independent risk factors affecting baPWV.
Conclusions: In this study, the increase serum GA, pulse pressure, mean blood pressure, and low HDL might be risk
factors of arterial stiffness in non-diabetic CKD patients. |